http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I646958-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fcbf0ceec413970d39781c0a93c5e5c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| filingDate | 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a63c4d7c48e9348d1e831a18fb8186b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71582a603cea4933c2996b1d7d6a452c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5d71308f83a5170a7428e4938b14897 |
| publicationDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I646958-B |
| titleOfInvention | Tomoxetine hydrochloride oral solution and method thereof |
| abstract | The invention discloses an oral pharmaceutical composition which uses aqueous solution of tomoxetine as its active ingredient. The aqueous solution of tomoxetine contains a taste-masking liquid carrier, and it contains mint, orange flavor, and thickener. The aforementioned comprehensive flavor effectively masks the bitter odor and / or taste of tomoxetine hydrochloride, making it a novel and delicious pharmaceutical composition. The thickener increases the consistency of the oral pharmaceutical composition and provides a smooth mouthfeel to make it easy to swallow. More specifically, the oral pharmaceutical composition comprises an effective amount of: (a) tomoxetine or a pharmaceutically acceptable salt thereof; and (b) a taste-masking liquid carrier. The present invention also provides a method for manufacturing the water-soluble tomoxetine. Furthermore, the present invention also provides a method for treating a subject with a treatable condition using the oral pharmaceutical composition, and the method is mainly oral tomoxetine. According to an embodiment of the present invention, the disorder is concentration disorder and hyperactivity disorder (ADHD). |
| priorityDate | 2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.